Lower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company Says

MONDAY, Sept. 20, 2021 (HealthDay News) -- A smaller dose of Pfizer's coronavirus vaccine safely triggers a strong immune response in children as young as 5, the company announced Monday morning.

"Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine. We are eager to extend the protection afforded by the vaccine to this younger population, subject to regulatory authorization, especially as we track the spread of the Delta variant and the substantial threat it poses to children," Pfizer Chairman and CEO Albert Bourla said in a statement.